Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $19.6700 (0.92%) ($19.4300 - $20.0000) on Tue. Sep. 27, 2011. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.8% (three month average) | RSI | 68 | Latest Price | $19.6700(0.92%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 4.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IWM(34%) QQQ(33%) SPY(33%) XLK(29%) XLY(28%) | Factors Impacting SGEN price | SGEN will decline at least -1.9% in a week (0% probabilities). TLT(-12%) SHY(-4%) TIP(-2%) IGOV(0%) LQD(3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.9% (StdDev 3.8%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
5 Day Moving Average | $19.63(0.2%) | 10 Day Moving Average | $19.26(2.13%) | 20 Day Moving Average | $18.46(6.55%) | To recent high | -7.8% | To recent low | 55.2% | Market Cap | $3.42b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |